Cytochrome P450 ω-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal K ATP channel

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 6, 2004, Pages 1245-1249

  Gross, Eric R ^a   Nithipatikom, Kasem ^a   Hsu, Anna K ^a   Peart, Jason N ^a   Falck, John R ^b   Campbell, William B ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

20 HETE; Cytochrome P450; Ischemia; K ATP; Reperfusion

Indexed keywords

17 OCTADECYNOIC ACID; 5 HYDROXYDECANOIC ACID; CLAMIKALANT; CYTOCHROME P450 INHIBITOR; CYTOCHROME P450 REDUCTASE; MICONAZOLE; N METHANESULFONYL 6 (2 PROPARGYLOXYPHENYL)HEXANAMIDE; N METHYLSULFONYL 12,12 DIBROMODODEC 11 ENAMIDE; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; HYDROXYEICOSATETRAENOIC ACIDS; MALE; MIXED FUNCTION OXYGENASES; MYOCARDIAL INFARCTION; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SARCOLEMMA;

EID: 9644279413     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.10.008     Document Type: Article

References (11)

1. I. Fleming Cytochrome P450 enzymes in vascular homeostasis Circ. Res. 89 2001 753 762
2. D.J. Granville, B. Tashakkor, C. Takeuchi, A.B. Gustafsson, C. Huang, and R. Sayen Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors Proc. Natl. Acad. Sci. 101 5 2004 1321 1326
3. K. Nithipatikom, R.F. DiCamelli, S. Kohler, R.J. Gumina, J.R. Falck, and W.B. Campbell Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs Anal. Biochem. 292 2001 115 124
4. K. Nithipatikom, E.R. Gross, M.P. Endsley, J.M. Moore, M.A. Isbell, and J.R. Falck Inhibition of cytochrome P450 ω-hydroxylases: a novel endogenous cardioprotective pathway Circ. Res. 95 2004 e65 e71
5. J. Seubert, B. Yang, J.A. Bradbury, J. Graves, L.M. Degraff, and S. Gabel Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/44 MAPK pathway Circ. Res. 95 2004 506 514
6. G.J. Gross, and J.N. Peart KATP channels and myocardial preconditioning: an update Am. J. Physiol. 285 2003 H921 H930
7. J.R. Falck, Y. Belosludtsev, K. Kishta-Reddy, K. Malla-Reddy, M. Fiona-Shortt, and K. Chauhan Eicosanoid biosynthesis: differential inhibition of cytochrome P450 epoxygenase and ω-hydroxylase Bioorg. Med. Chem. 7 1997 3053 3056
8. E.R. Gross, A.K. Hsu, and G.J. Gross Opioid-induced cardioprotection occurs via glycogen synthase kinase β inhibition during reperfusion in intact rat hearts Circ. Res. 94 2004 960 966
9. A. Rane, Z. Liu, C.J. Henderson, and C.R. Wolf Divergent regulation of cytochrome P450 enzymes by morphine and pethidine: a neuroendocrine mechanism? Mol. Pharmcol. 47 1995 57 64
10. P.E. Light, H.D. Kanjii, J.E. Fox, and R.J. French Distinct myoprotective roles of cardiac sarcolemmal and mitochondrial KATP channels during metabolic inhibition and recovery FASEB 15 2001 2586 2594
11. ATP channels in adenosine-enhanced ischemic preconditioning Am. J. Physiol. 279 2000 H2694 H2703